Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 195

1.

Tyrosine kinase inhibitors and immune checkpoint inhibitors-induced thyroid disorders.

Jannin A, Penel N, Ladsous M, Vantyghem MC, Cao CD.

Crit Rev Oncol Hematol. 2019 May 31;141:23-35. doi: 10.1016/j.critrevonc.2019.05.015. [Epub ahead of print] Review.

PMID:
31202955
2.

Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies.

Wahbi K, Ben Yaou R, Gandjbakhch E, Anselme F, Gossios T, Lakdawala NK, Stalens C, Sacher F, Babuty D, Trochu JN, Moubarak G, Savvatis K, Porcher R, Laforêt P, Fayssoil A, Marijon E, Stojkovic T, Béhin A, Leonard-Louis S, Sole G, Labombarda F, Richard P, Metay C, Quijano-Roy S, Dabaj I, Klug D, Vantyghem MC, Chevalier P, Ambrosi P, Salort E, Sadoul N, Waintraub X, Chikhaoui K, Mabo P, Combes N, Maury P, Sellal JM, Tedrow UB, Kalman JM, Vohra J, Androulakis AFA, Zeppenfeld K, Thompson T, Barnerias C, Bécane HM, Bieth E, Boccara F, Bonnet D, Bouhour F, Boulé S, Brehin AC, Chapon F, Cintas P, Cuisset JM, Davy JM, De Sandre-Giovannoli A, Demurger F, Desguerre I, Dieterich K, Durigneux J, Echaniz-Laguna A, Eschalier R, Ferreiro A, Ferrer X, Francannet C, Fradin M, Gaborit B, Gay A, Hagège A, Isapof A, Jeru I, Morales RJ, Lagrue E, Lamblin N, Lascols O, Laugel V, Lazarus A, Leturcq F, Levy N, Magot A, Manel V, Martins R, Mayer M, Mercier S, Meune C, Michaud M, Minot-Myhié MC, Muchir A, Nadaj-Pakleza A, Péréon Y, Petiot P, Petit F, Praline J, Rollin A, Sabouraud P, Sarret C, Schaeffer S, Taithe F, Tard C, Tiffreau V, Toutain A, Vatier C, Walther-Louvier U, Eymard B, Charron P, Vigouroux C, Bonne G, Kumar S, Elliott P, Duboc D.

Circulation. 2019 Jun 3. doi: 10.1161/CIRCULATIONAHA.118.039410. [Epub ahead of print]

PMID:
31155932
3.

[Islet and whole pancreas transplantation in type 1 diabetes].

Chetboun M, Humbert L, Pattou F, Vantyghem MC.

Rev Prat. 2018 Jun;68(6):628-631. French. No abstract available.

PMID:
30869251
4.

Lesson from inappropriate TSH-receptor antibody measurement in hypothyroidism: case series and literature review.

Jannin A, Peltier L, d'Herbomez M, Defrance F, Marcelli S, Ben Hamou A, Humbert L, Wémeau JL, Vantyghem MC, Espiard S.

Clin Chem Lab Med. 2019 Mar 8. pii: /j/cclm.ahead-of-print/cclm-2019-0090/cclm-2019-0090.xml. doi: 10.1515/cclm-2019-0090. [Epub ahead of print] No abstract available.

PMID:
30849043
5.

Systematic thyroid screening in myotonic dystrophy: link between thyroid volume and insulin resistance.

Ben Hamou A, Espiard S, Do Cao C, Ladsous M, Loyer C, Moerman A, Boury S, Kyheng M, Dhaenens CM, Tiffreau V, Pigny P, Lebuffe G, Caiazzo R, Aubert S, Vantyghem MC.

Orphanet J Rare Dis. 2019 Feb 13;14(1):42. doi: 10.1186/s13023-019-1019-3.

6.

Chronic Mucocutaneous Candidiasis in Autoimmune Polyendocrine Syndrome Type 1.

Humbert L, Cornu M, Proust-Lemoine E, Bayry J, Wemeau JL, Vantyghem MC, Sendid B.

Front Immunol. 2018 Nov 19;9:2570. doi: 10.3389/fimmu.2018.02570. eCollection 2018. Review.

7.

Monogenic forms of lipodystrophic syndromes: diagnosis, detection, and practical management considerations from clinical cases.

Vatier C, Vantyghem MC, Storey C, Jéru I, Christin-Maitre S, Fève B, Lascols O, Beltrand J, Carel JC, Vigouroux C, Bismuth E.

Curr Med Res Opin. 2019 Mar;35(3):543-552. doi: 10.1080/03007995.2018.1533459. Epub 2018 Nov 9.

PMID:
30296183
8.

Cardiometabolic assessment of lamin A/C gene mutation carriers: A phenotype-genotype correlation.

Kwapich M, Lacroix D, Espiard S, Ninni S, Brigadeau F, Kouakam C, Degroote P, Laurent JM, Tiffreau V, Jannin A, Humbert L, Ben Hamou A, Tard C, Ben Yaou R, Lamblin N, Klug D, Richard P, Vigouroux C, Bonne G, Vantyghem MC; Diamenord–AEDNL Working Group.

Diabetes Metab. 2018 Oct 1. pii: S1262-3636(18)30177-0. doi: 10.1016/j.diabet.2018.09.006. [Epub ahead of print]

PMID:
30287275
9.

Indications for islet or pancreatic transplantation: Statement of the TREPID working group on behalf of the Société francophone du diabète (SFD), Société francaise d'endocrinologie (SFE), Société francophone de transplantation (SFT) and Société française de néphrologie - dialyse - transplantation (SFNDT).

Wojtusciszyn A, Branchereau J, Esposito L, Badet L, Buron F, Chetboun M, Kessler L, Morelon E, Berney T, Pattou F, Benhamou PY, Vantyghem MC; TREPID group.

Diabetes Metab. 2019 Jun;45(3):224-237. doi: 10.1016/j.diabet.2018.07.006. Epub 2018 Sep 14. Review.

PMID:
30223084
10.

Irisin levels in LMNA-associated partial lipodystrophies.

Bensmaïne F, Benomar K, Espiard S, Vahe C, Le Mapihan K, Lion G, Lemdani M, Chazard E, Ernst O, Vigouroux C, Pigny P, Vantyghem MC.

Diabetes Metab. 2019 Jan;45(1):67-75. doi: 10.1016/j.diabet.2018.08.003. Epub 2018 Aug 27.

PMID:
30165155
11.

Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a multicentre, randomised controlled trial.

Lablanche S, Vantyghem MC, Kessler L, Wojtusciszyn A, Borot S, Thivolet C, Girerd S, Bosco D, Bosson JL, Colin C, Tetaz R, Logerot S, Kerr-Conte J, Renard E, Penfornis A, Morelon E, Buron F, Skaare K, Grguric G, Camillo-Brault C, Egelhofer H, Benomar K, Badet L, Berney T, Pattou F, Benhamou PY; TRIMECO trial investigators.

Lancet Diabetes Endocrinol. 2018 Jul;6(7):527-537. doi: 10.1016/S2213-8587(18)30078-0. Epub 2018 May 15.

PMID:
29776895
12.

[Androgens and cardiovascular risk: A series of case report in the French and Canadian pharmacovigilance databases].

Rochoy M, Thomas R, Béné J, Deleplanque D, Vantyghem MC, Gautier S, Deplanque D; Réseaux français de pharmacovigilance.

Prog Urol. 2018 May;28(6):315-321. doi: 10.1016/j.purol.2018.03.005. Epub 2018 Apr 9. French.

PMID:
29650456
13.

Hyperinsulinemic hypoglycemia without insulinoma: Think of activating glucokinase mutation.

Jannin A, Espiard S, Douillard C, Pasquier F, Bellanné-Chantelot C, Vantyghem MC.

Presse Med. 2018 Jun;47(6):595-597. doi: 10.1016/j.lpm.2018.02.015. Epub 2018 Mar 17. No abstract available.

PMID:
29555163
14.

Non-islet-cell tumour hypoglycaemia (NICTH): About a series of 6 cases.

Jannin A, Espiard S, Benomar K, Do Cao C, Mycinski B, Porte H, D'Herbomez M, Penel N, Vantyghem MC.

Ann Endocrinol (Paris). 2019 Feb;80(1):21-25. doi: 10.1016/j.ando.2018.01.005. Epub 2018 Mar 16.

PMID:
29555080
15.

Defining Outcomes for β-cell Replacement Therapy in the Treatment of Diabetes: A Consensus Report on the Igls Criteria From the IPITA/EPITA Opinion Leaders Workshop.

Rickels MR, Stock PG, de Koning EJP, Piemonti L, Pratschke J, Alejandro R, Bellin MD, Berney T, Choudhary P, Johnson PR, Kandaswamy R, Kay TWH, Keymeulen B, Kudva YC, Latres E, Langer RM, Lehmann R, Ludwig B, Markmann JF, Marinac M, Odorico JS, Pattou F, Senior PA, Shaw JAM, Vantyghem MC, White S.

Transplantation. 2018 Sep;102(9):1479-1486. doi: 10.1097/TP.0000000000002158. Review.

16.

[Atrial natriuretic hormones and metabolic syndrome: recent advances].

Benomar K, Espiard S, Loyer C, Jannin A, Vantyghem MC.

Presse Med. 2018 Feb;47(2):116-124. doi: 10.1016/j.lpm.2017.12.002. Epub 2018 Feb 27. Review. French.

PMID:
29496376
17.

Hepatic safety of ketoconazole in Cushing's syndrome: results of a Compassionate Use Programme in France.

Young J, Bertherat J, Vantyghem MC, Chabre O, Senoussi S, Chadarevian R, Castinetti F; Compassionalte use Programme.

Eur J Endocrinol. 2018 May;178(5):447-458. doi: 10.1530/EJE-17-0886. Epub 2018 Feb 22.

PMID:
29472378
18.

Defining outcomes for β-cell replacement therapy in the treatment of diabetes: a consensus report on the Igls criteria from the IPITA/EPITA opinion leaders workshop.

Rickels MR, Stock PG, de Koning EJP, Piemonti L, Pratschke J, Alejandro R, Bellin MD, Berney T, Choudhary P, Johnson PR, Kandaswamy R, Kay TWH, Keymeulen B, Kudva YC, Latres E, Langer RM, Lehmann R, Ludwig B, Markmann JF, Marinac M, Odorico JS, Pattou F, Senior PA, Shaw JAM, Vantyghem MC, White S.

Transpl Int. 2018 Apr;31(4):343-352. doi: 10.1111/tri.13138. Review.

19.

European recommendations for the management of adrenal incidentalomas: A debate on patients follow-up.

Espiard S, Benomar K, Loyer C, Vahé C, Vantyghem MC.

Ann Endocrinol (Paris). 2018 Feb;79(1):45-48. doi: 10.1016/j.ando.2017.08.002. Epub 2017 Dec 11. No abstract available.

PMID:
29241951
20.

Actualisation sur l’hypoparathyroïdie : un peu de théorie, beaucoup de pratique: Update on hypoparathyroidism: a little theory, a lot of practice.

Espiard S, Vantyghem MC, Desailloud R.

Ann Endocrinol (Paris). 2017 Oct;78 Suppl 1:S1-S10. doi: 10.1016/S0003-4266(17)30920-4. Review. French.

PMID:
29157484
21.

Purity of islet preparations and 5-year metabolic outcome of allogenic islet transplantation.

Benomar K, Chetboun M, Espiard S, Jannin A, Le Mapihan K, Gmyr V, Caiazzo R, Torres F, Raverdy V, Bonner C, D'Herbomez M, Pigny P, Noel C, Kerr-Conte J, Pattou F, Vantyghem MC.

Am J Transplant. 2018 Apr;18(4):945-951. doi: 10.1111/ajt.14514. Epub 2017 Nov 11.

22.

Enteroviruses in blood of patients with type 1 diabetes detected by integrated cell culture and reverse transcription quantitative real-time PCR.

Alidjinou EK, Sane F, Lefevre C, Baras A, Moumna I, Engelmann I, Vantyghem MC, Hober D.

Acta Diabetol. 2017 Nov;54(11):1025-1029. doi: 10.1007/s00592-017-1041-7. Epub 2017 Aug 31.

PMID:
28861621
23.

Effect of insulin infusion line on glycaemic variability in a perioperative high dependency unit (HDU): a prospective randomised controlled trial.

Genay S, Décaudin B, Ethgen S, Alluin A, Babol E, Labreuche J, Behal H, Vantyghem MC, Odou P, Lebuffe G.

Ann Intensive Care. 2017 Dec;7(1):74. doi: 10.1186/s13613-017-0298-x. Epub 2017 Jul 11.

24.

Erratum to: Laparoscopic adrenalectomy by transabdominal lateral approach: 20 years of experience.

Coste T, Caiazzo R, Torres F, Vantyghem MC, Carnaille B, Do Cao C, Douillard C, Pattou F.

Surg Endosc. 2017 Jul;31(7):2752. doi: 10.1007/s00464-017-5437-9. No abstract available.

PMID:
28600776
25.

LMNA-associated partial lipodystrophy: anticipation of metabolic complications.

Jeru I, Vatier C, Vantyghem MC, Lascols O, Vigouroux C.

J Med Genet. 2017 Jun;54(6):413-416. doi: 10.1136/jmedgenet-2016-104437. Epub 2017 Apr 13.

PMID:
28408391
26.

Randomised, prospective, medico-economic nationwide French study of islet transplantation in patients with severely unstable type 1 diabetes: the STABILOT study protocol.

Lablanche S, David-Tchouda S, Margier J, Schir E, Wojtusciszyn A, Borot S, Kessler L, Morelon E, Thivolet C, Pattou F, Vantyghem MC, Berney T, Benhamou PY.

BMJ Open. 2017 Feb 20;7(2):e013434. doi: 10.1136/bmjopen-2016-013434.

27.

Foxa2, a novel protein partner of the tumour suppressor menin, is deregulated in mouse and human MEN1 glucagonomas.

Bonnavion R, Teinturier R, Gherardi S, Leteurtre E, Yu R, Cordier-Bussat M, Du R, Pattou F, Vantyghem MC, Bertolino P, Lu J, Zhang CX.

J Pathol. 2017 May;242(1):90-101. doi: 10.1002/path.4885. Epub 2017 Mar 27.

PMID:
28188614
28.

Diseases associated with calcium-sensing receptor.

Vahe C, Benomar K, Espiard S, Coppin L, Jannin A, Odou MF, Vantyghem MC.

Orphanet J Rare Dis. 2017 Jan 25;12(1):19. doi: 10.1186/s13023-017-0570-z. Review.

29.

Post-transplantation diabetes: Treatment à la carte?

Benomar K, Espiard S, Vahe C, Le Mapihan K, Jannin A, Dharancy S, Hazzan M, Vantyghem MC.

Diabetes Metab. 2017 Sep;43(4):378-381. doi: 10.1016/j.diabet.2016.09.011. Epub 2016 Nov 10. Review. No abstract available.

PMID:
27840114
30.

Laparoscopic adrenalectomy by transabdominal lateral approach: 20 years of experience.

Coste T, Caiazzo R, Torres F, Vantyghem MC, Carnaille B, Do Cao C, Douillard C, Pattou F.

Surg Endosc. 2017 Jul;31(7):2743-2751. doi: 10.1007/s00464-016-4830-0. Epub 2016 Nov 10. Erratum in: Surg Endosc. 2017 Jul;31(7):2752.

PMID:
27834023
31.

Incidence and Predictive Factors of Postprandial Hyperinsulinemic Hypoglycemia After Roux-en-Y Gastric Bypass: A Five year Longitudinal Study.

Raverdy V, Baud G, Pigeyre M, Verkindt H, Torres F, Preda C, Thuillier D, Gélé P, Vantyghem MC, Caiazzo R, Pattou F.

Ann Surg. 2016 Nov;264(5):878-885.

PMID:
27560624
32.

PKA regulatory subunit 1A inactivating mutation induces serotonin signaling in primary pigmented nodular adrenal disease.

Bram Z, Louiset E, Ragazzon B, Renouf S, Wils J, Duparc C, Boutelet I, Rizk-Rabin M, Libé R, Young J, Carson D, Vantyghem MC, Szarek E, Martinez A, Stratakis CA, Bertherat J, Lefebvre H.

JCI Insight. 2016 Sep 22;1(15):e87958. doi: 10.1172/jci.insight.87958.

33.

One-year metreleptin therapy decreases PCSK9 serum levels in diabetic patients with monogenic lipodystrophy syndromes.

Vatier C, Arnaud L, Prieur X, Guyomarch B, Le May C, Bigot E, Pichelin M, Daguenel A, Vantyghem MC, Gautier JF, Vigouroux C, Cariou B.

Diabetes Metab. 2017 Jun;43(3):275-279. doi: 10.1016/j.diabet.2016.08.004. Epub 2016 Sep 28. No abstract available.

PMID:
27692500
34.

Hyperparathyroidism complicating CYP 24A1 mutations.

Loyer C, Leroy C, Molin A, Odou MF, Huglo D, Lion G, Ernst O, Hoffmann M, Porchet N, Carnaille B, Pattou F, Kottler ML, Vantyghem MC.

Ann Endocrinol (Paris). 2016 Oct;77(5):615-619. doi: 10.1016/j.ando.2016.03.002. Epub 2016 Jul 1.

PMID:
27378451
35.

LMNA mutations resulting in lipodystrophy and HIV protease inhibitors trigger vascular smooth muscle cell senescence and calcification: Role of ZMPSTE24 downregulation.

Afonso P, Auclair M, Boccara F, Vantyghem MC, Katlama C, Capeau J, Vigouroux C, Caron-Debarle M.

Atherosclerosis. 2016 Feb;245:200-11. doi: 10.1016/j.atherosclerosis.2015.12.012. Epub 2015 Dec 20.

PMID:
26724531
36.

CA-125, but not galectin-3, complements CA 19-9 for discriminating ductal adenocarcinoma versus non-malignant pancreatic diseases.

Coppin L, Benomar K, Corfiotti F, Cattan S, Renaud F, Lapere C, Leteurtre E, Vantyghem MC, Truant S, Pigny P.

Pancreatology. 2016 Jan-Feb;16(1):115-20. doi: 10.1016/j.pan.2015.10.008. Epub 2015 Nov 11.

PMID:
26613889
37.

One-year metreleptin improves insulin secretion in patients with diabetes linked to genetic lipodystrophic syndromes.

Vatier C, Fetita S, Boudou P, Tchankou C, Deville L, Riveline J, Young J, Mathivon L, Travert F, Morin D, Cahen J, Lascols O, Andreelli F, Reznik Y, Mongeois E, Madelaine I, Vantyghem M, Gautier J, Vigouroux C.

Diabetes Obes Metab. 2016 Jul;18(7):693-7. doi: 10.1111/dom.12606. Epub 2016 Jan 12.

PMID:
26584826
38.

Ectopic Subcutaneous Implantation of Thyroid Tissue After Gasless Transaxillary Robotic Thyroidectomy for Papillary Thyroid Cancer.

Espiard S, Petyt G, Lion G, Béron A, Do Cao C, Wémeau JL, Vantyghem MC, Pattou F, Caiazzo R.

Thyroid. 2015 Dec;25(12):1381-2. doi: 10.1089/thy.2015.0177. No abstract available.

PMID:
26563453
39.

Immunosuppressive drugs and fertility.

Leroy C, Rigot JM, Leroy M, Decanter C, Le Mapihan K, Parent AS, Le Guillou AC, Yakoub-Agha I, Dharancy S, Noel C, Vantyghem MC.

Orphanet J Rare Dis. 2015 Oct 21;10:136. doi: 10.1186/s13023-015-0332-8. Review.

40.

Hormonal, Radiological, NP-59 Scintigraphy, and Pathological Correlations in Patients With Cushing's Syndrome Due to Primary Pigmented Nodular Adrenocortical Disease (PPNAD).

Vezzosi D, Tenenbaum F, Cazabat L, Tissier F, Bienvenu M, Carrasco CA, Laloi-Michelin M, Barrande G, Lefebvre H, Hiéronimus S, Tabarin A, Bertagna X, Legmann P, Vantyghem MC, Bertherat J.

J Clin Endocrinol Metab. 2015 Nov;100(11):4332-8. doi: 10.1210/jc.2015-2174. Epub 2015 Sep 21.

PMID:
26390100
41.

An unexpected cause of cardiomyopathy revealed by arrhythmias and conduction disorders in an athlete.

Potelle C, Vantyghem MC, Verbrugge E, Coisne A, Lacroix D.

Int J Cardiol. 2015 Dec 15;201:228-30. doi: 10.1016/j.ijcard.2015.08.009. Epub 2015 Aug 3. No abstract available.

PMID:
26301643
42.

CYP24A1 Mutations in a Cohort of Hypercalcemic Patients: Evidence for a Recessive Trait.

Molin A, Baudoin R, Kaufmann M, Souberbielle JC, Ryckewaert A, Vantyghem MC, Eckart P, Bacchetta J, Deschenes G, Kesler-Roussey G, Coudray N, Richard N, Wraich M, Bonafiglia Q, Tiulpakov A, Jones G, Kottler ML.

J Clin Endocrinol Metab. 2015 Oct;100(10):E1343-52. doi: 10.1210/jc.2014-4387. Epub 2015 Jul 27.

PMID:
26214117
43.

Islet Cells Serve as Cells of Origin of Pancreatic Gastrin-Positive Endocrine Tumors.

Bonnavion R, Teinturier R, Jaafar R, Ripoche D, Leteurtre E, Chen YJ, Rehfeld JF, Lepinasse F, Hervieu V, Pattou F, Vantyghem MC, Scoazec JY, Bertolino P, Zhang CX.

Mol Cell Biol. 2015 Oct;35(19):3274-83. doi: 10.1128/MCB.00302-15. Epub 2015 Jul 13.

44.

Monocytes of Patients with Type 1 Diabetes Harbour Enterovirus RNA.

Alidjinou EK, Chehadeh W, Weill J, Vantyghem MC, Stuckens C, Decoster A, Hober C, Hober D.

Eur J Clin Invest. 2015 Sep;45(9):918-24. doi: 10.1111/eci.12485. Epub 2015 Aug 6.

PMID:
26108863
45.

Management of nonfunctioning pituitary incidentaloma.

Galland F, Vantyghem MC, Cazabat L, Boulin A, Cotton F, Bonneville JF, Jouanneau E, Vidal-Trécan G, Chanson P.

Ann Endocrinol (Paris). 2015 Jul;76(3):191-200. doi: 10.1016/j.ando.2015.04.004. Epub 2015 Jun 6. Review.

46.

Evidence-informed clinical practice recommendations for treatment of type 1 diabetes complicated by problematic hypoglycemia.

Choudhary P, Rickels MR, Senior PA, Vantyghem MC, Maffi P, Kay TW, Keymeulen B, Inagaki N, Saudek F, Lehmann R, Hering BJ.

Diabetes Care. 2015 Jun;38(6):1016-29. doi: 10.2337/dc15-0090. Review.

47.

15q11.2 microdeletion (BP1-BP2) and developmental delay, behaviour issues, epilepsy and congenital heart disease: a series of 52 patients.

Vanlerberghe C, Petit F, Malan V, Vincent-Delorme C, Bouquillon S, Boute O, Holder-Espinasse M, Delobel B, Duban B, Vallee L, Cuisset JM, Lemaitre MP, Vantyghem MC, Pigeyre M, Lanco-Dosen S, Plessis G, Gerard M, Decamp M, Mathieu M, Morin G, Jedraszak G, Bilan F, Gilbert-Dussardier B, Fauvert D, Roume J, Cormier-Daire V, Caumes R, Puechberty J, Genevieve D, Sarda P, Pinson L, Blanchet P, Lemeur N, Sheth F, Manouvrier-Hanu S, Andrieux J.

Eur J Med Genet. 2015 Mar;58(3):140-7. doi: 10.1016/j.ejmg.2015.01.002. Epub 2015 Jan 14.

PMID:
25596525
48.

Management of endocrino-metabolic dysfunctions after allogeneic hematopoietic stem cell transplantation.

Vantyghem MC, Cornillon J, Decanter C, Defrance F, Karrouz W, Leroy C, Le Mapihan K, Couturier MA, De Berranger E, Hermet E, Maillard N, Marcais A, Francois S, Tabrizi R, Yakoub-Agha I; Société Française de Thérapie Cellulaire.

Orphanet J Rare Dis. 2014 Oct 29;9:162. doi: 10.1186/s13023-014-0162-0. Review.

49.

Potential role of parasitosis in tumorigenesis: case study of heart metastasis as the only presenting symptom of an ileal neuroendocrine tumor.

Beaujot J, Leteurtre E, Do Cao C, Beron A, Caiazzo R, Vantyghem MC.

Presse Med. 2015 Jan;44(1):102-6. doi: 10.1016/j.lpm.2014.05.020. Epub 2014 Oct 31. No abstract available.

PMID:
25455631
50.

Impact of Procedure-Related Complications on Long-term Islet Transplantation Outcome.

Caiazzo R, Vantyghem MC, Raverdi V, Bonner C, Gmyr V, Defrance F, Leroy C, Sergent G, Hubert T, Ernst O, Noel C, Kerr-Conte J, Pattou F.

Transplantation. 2015 May;99(5):979-84. doi: 10.1097/TP.0000000000000458.

PMID:
25393157

Supplemental Content

Loading ...
Support Center